Apoa5(bd) (AA 180-363) anticorps

N° du produit ABIN968960

Détail du produit

Antigène: Apoa5(bd)

Épitope: AA 180-363

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: ELISA

Purification: purified

Immunogène: Purified recombinant fragment of human APOA5 (AA: 180-363) expressed in E. coli.

Clone: 4H8H8E2(c)

Isotype: IgG1

Information d'application

Indications d'application: ELISA: 1:10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-20 °C

Stockage commentaire: 4°C, -20°C for long term storage

Détail du antigène

Antigène: Apoa5(bd)

Autre désignation: Apoa5 (bd)

Sujet:

Description: Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglyc erides, whereas a knock-in model with human ApoA5 produced 50-70 % lower , , concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.

Aliases: RAP3, APOAV, APOA-V

Poids moléculaire: 41.2 kDa

ID gène: 116519

HGNC: 116519